Yang, Jin-Chen
Rodriguez, Annette
Royston, Ashley
Niu, Yu-Qiong
Avar, Merve
Brill, Ryan
Simon, Christa
Grigsby, Jim
Hagerman, Randi J.
Olichney, John M.
Article History
Received: 23 September 2015
Accepted: 29 January 2016
First Online: 22 February 2016
Competing interests
: There is potential competing interest. Dr. Hagerman has consulted with Novartis regarding clinical trials in fragile X syndrome. Dr. Olichney receives support from Genentech for a clinical drug trial and has served as a consultant for Lundbeck Pharmaceuticals.